Shares of Bausch + Lomb ( BLCO 14.47%) rallied 15.7% as of 3:07 p.m. ET today. The stock is surging today on news the company is considering selling itself. Of note, Bausch + Lomb is the eye-care ...
Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...
This week, the Federal Reserve's decision to reduce interest rates by 50 basis points boosted share prices across the ...
Key Takeaways Bausch + Lomb is discussing a possible sale that would separate it from its parent company, Bausch Health ...
Financial writers report on private equity interest in a potential takeover of Bausch & Lomb, with firms like Blackstone and ...
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a ...
Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a market cap of $6.27 billion on Monday.
14d
Larry Biegelsen, an analyst from Wells Fargo, assigned the Buy rating on Bausch + Lomb Corporation (BLCO – Research Report). The ...
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback